Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2013-05-01
2016-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Autologous Fat Grafting in Upper Limb Burns Scars
NCT07186322
Fractional Ablative Laser Treatment for Skin Grafts
NCT04176705
Application of Cultured Autologous Keratinocytes for Burn Wound Healing
NCT00832156
Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale
NCT04781348
Evaluation of the Product Properties of Individualized 3D-compression Garments to Treat Scars
NCT03664505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: Included patients received split-thickness skin grafting procedures for deep burn wounds less than 3 months ago. A homogenous scar area in each patient was divided into two equal parts. One part was treated with transcutaneous sharp needle autologous fat grafting, the adjacent part with transcutaneous saline injection as control. Results were evaluated by clinical assessment with scar scale questionnaires, histological examination, and objective scar assessment with Cutometer, Mexameter, Tewameter and Corneometer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 group of 15 patients
procedure/surgery: fat grafting injection of scar
lipofilling/ fat grafting
liposuction, processing/ cleaning of fat tissue; reinjection with sharp needle transcutaneous
Same group of 15 patients
procedure/surgery: placebo injection of scar
placebo injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lipofilling/ fat grafting
liposuction, processing/ cleaning of fat tissue; reinjection with sharp needle transcutaneous
placebo injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* otherwise healthy
Exclusion Criteria
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phillip Blondeel
Clinical Professor, Head of Plastic Surgery, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maarten AJ Doornaert, MD
Role: PRINCIPAL_INVESTIGATOR
UGent University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC 2010/ 572
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.